Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review

The current standard of care for advanced non-small-cell lung cancer is based on detecting actionable mutations that can benefit from targeted therapy. Comprehensive genetic tests can have long turn-around times, and because EGFR mutations are the most prevalent actionable mutation, a quick detectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Caputo, Alessandro, D’Ardia, Angela, Sabbatino, Francesco, Picariello, Caterina, Ciaparrone, Chiara, Zeppa, Pio, D’Antonio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125729/
https://www.ncbi.nlm.nih.gov/pubmed/34063720
http://dx.doi.org/10.3390/ijms22094852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125729/
https://www.ncbi.nlm.nih.gov/pubmed/34063720
http://dx.doi.org/10.3390/ijms22094852

Ejemplares similares